BNP PARIBAS FINANCIAL MARKETS - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 115 filers reported holding Y-MABS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$73,537
+12.8%
13,493
+40.6%
0.00%
Q2 2023$65,164
-63.4%
9,597
-73.0%
0.00%
Q1 2023$177,875
+6.0%
35,504
+3.2%
0.00%
Q4 2022$167,852
-100.0%
34,396
-11.8%
0.00%
-100.0%
Q3 2022$562,539,000
+365.9%
39,011
+388.9%
0.00%
Q2 2022$120,737,000
+247.1%
7,980
+172.5%
0.00%
Q1 2022$34,785,000
-76.4%
2,928
-67.8%
0.00%
Q4 2021$147,511,000
-19.9%
9,100
+41.1%
0.00%
Q3 2021$184,054,000
+256.4%
6,449
+322.1%
0.00%
Q2 2021$51,646,000
-83.4%
1,528
-85.1%
0.00%
Q1 2021$310,414,000
-90.8%
10,265
-84.9%
0.00%
-100.0%
Q4 2020$3,361,977,000
+1142.4%
67,905
+863.3%
0.01%
Q3 2020$270,611,000
+193.1%
7,049
+229.9%
0.00%
Q2 2020$92,318,000
-65.8%
2,137
-79.3%
0.00%
-100.0%
Q1 2020$269,744,000
+214.6%
10,335
+276.6%
0.00%
Q4 2019$85,750,000
+17.2%
2,744
-2.3%
0.00%
Q3 2019$73,176,000
+274.2%
2,808
+228.4%
0.00%
Q2 2019$19,554,000
-48.4%
855
-40.9%
0.00%
Q1 2019$37,926,0001,4470.00%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 191,176$2,271,0002.63%
Sofinnova Investments, Inc. 2,194,278$26,068,0001.98%
MPM BioImpact LLC 443,702$5,271,0001.42%
Soleus Capital Management, L.P. 238,982$2,839,0000.37%
Lombard Odier Asset Management (Switzerland) SA 221,774$2,635,0000.21%
Artal Group S.A. 400,000$4,752,0000.20%
Polar Capital Holdings Plc 2,877,671$34,187,0000.15%
ASHFORD CAPITAL MANAGEMENT INC 106,770$1,268,0000.14%
Cormorant Asset Management, LP 150,000$1,782,0000.14%
Virtus ETF Advisers LLC 23,646$281,0000.13%
View complete list of Y-MABS THERAPEUTICS INC shareholders